COVID-19: Vaccine safety post-market surveillance

Canada has several systems in place to monitor the safety and effectiveness of vaccines starting in the early development stage and continuing for as long as the vaccines are in use. Get the facts. Visit Canada.ca/covid-vaccine to learn more.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:57 (UTC)
Created April 17, 2026, 17:57 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-07-14 00:00:00
open_canada_keywords {"fr": ["COVID-19", "Surveillance de l’innocuité des vaccins", "après leur mise en marché", "surveillance", "des vaccins", "sécurité des vaccins", "Vaccin contre le covid-19", "Efficacité des vaccins", "Immunité collective", "programmes de vaccination", "coronavirus", "COVID", "pandémie"], "en": ["COVID-19", "Vaccine safety", "post-market surveillance", "surveillance", "vaccines", "vaccine safety", "COVID-19 vaccine", "vaccine effectiveness", "Community immunity", "vaccination programs", "coronavirus", "COVID", "pandemic"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr COVID-19: Surveillance de l’innocuité des vaccins après leur mise en marché
update_frequency unknown